Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.

Sommer AK, Hermawan A, Mickler FM, Ljepoja B, Knyazev P, Brauchle C, Ullrich A, Wagner E, Roidl A
Oncotarget. 2016 Aug 2;7(31):50461-50476. doi: 10.18632/oncotarget.10459. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.